REPL
USDReplimune Group Inc. Common Stock
$8.970-0.220 (-2.394%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$9.190
High
$9.410
Low
$8.910
Volume
2.35M
Company Fundamentals
Market Cap
700.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
5.54M
Exchange
NMS
Currency
USD
52-Week Range
Low $2.68Current $8.970High $17
Related News
Analyst Upgrades
BMO Capital Upgrades Replimune Group to Market Perform, Raises Price Target to $11
BMO Capital analyst Evan David Seigerman upgrades Replimune Group from Underperform to Market Perform and raises the price target from $2 to $11.
View more
Analyst Upgrades
HC Wainwright & Co. Upgrades Replimune Group to Buy, Announces $12 Price Target
HC Wainwright & Co. analyst Robert Burns upgrades Replimune Group from Neutral to Buy and announces $12 price target.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.